1. Eshima D, Taylor A Jr. Technetium-99m (99mTc) mercaptoacetyltriglycine: update on the new 99m Tc renal tubular function agent. Semin Nucl Med. 1992;22:61–73.
2. Marcus CS, Kuperus JH. Pediatric renal I-123 orthoiodohippurate dosimetry. J Nucl Med. 1985;26:1211–4.
3. Stabin M, Taylor A, Eshima D, Wooten W. Radiation dosimetry for technetium-99m-MAG3, technetium-99m-DTPA, and iodine-131-OIH based on human biodistribution studies. J Nucl Med. 1992;33:33–40.
4. Bubeck B, Brandau W, Weber E, et al. Pharmacokinetics of technetium-99m-MAG3 in humans. J Nucl Med. 1990;31:1285–93.
5. Schaap GH, Alferink THR, deJong RBJ, et al. Tc-99m MAG3: dynamic studies in patients with renal diseases. Eur J Nucl Med. 1988;14:28–31.